Frontlight ResearchEarly access
Trial site
Istituto Nazionale Tumori IRCCS Fondazione Pascale
- 8running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Head and neck cancer4 trials
- Ovarian cancer4 trials
- Pancreatic cancer4 trials
- Colorectal cancer3 trials
- Melanoma3 trials
- Bladder cancer2 trials
- Liver and biliary tract cancer2 trials
- Metastatic breast cancer2 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- and 5 more
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 13 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Terminated2 trials
- Suspended1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Incyte Corporation3 trials
- Bristol-Myers Squibb2 trials
- Ariad Pharmaceuticals1 trial
- Eisai Inc.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer3 recruiting
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Ovarian cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Completed
Terminated
Completed
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026